Basic information Safety Supplier Related

OTAVA-BB 7070707015

Basic information Safety Supplier Related

OTAVA-BB 7070707015 Basic information

Product Name:
OTAVA-BB 7070707015
Synonyms:
  • OTAVA-BB 7070707015
  • CAY10585
  • HIF-1α inhibitor
  • LW6
  • LW8
  • CAY 10585;CAY-10585;CAY10585;LW6
  • 4-Hydroxy-3-[[2-(4-tricyclo[3.3.1.13,7]dec-1-ylphenoxy)acetyl]aMino]-benzoic Acid Methyl Ester
  • Hypoxia inducible factor-1α inhibitor
CAS:
934593-90-5
MF:
C26H29NO5
MW:
435.51
Product Categories:
  • Aromatics, Inhibitors
Mol File:
934593-90-5.mol
More
Less

OTAVA-BB 7070707015 Chemical Properties

Boiling point:
647.4±55.0 °C(Predicted)
Density 
1.295±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:17.5(Max Conc. mg/mL);40.18(Max Conc. mM)
DMF:25.6(Max Conc. mg/mL);58.8(Max Conc. mM)
pka
7.59±0.48(Predicted)
form 
powder to crystal
color 
White to Light yellow to Light orange
More
Less

Safety Information

HS Code 
2924.29.7790
More
Less

OTAVA-BB 7070707015 Usage And Synthesis

Description

Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor composed of a HIF-1α subunit and HIF-1β subunit. Whereas the HIF-1β subunit is constitutively expressed, the HIF-1α subunit is regulated by cellular oxygen levels and therefore plays an important role in maintaining cellular oxygen homeostasis. Under normoxic conditions, HIF-1α is selectively hydroxylated on proline residues 402 and 577 and targeted for destruction by the ubiquitin-proteasome system. Under hypoxic conditions, HIF-1α accumulates and dimerizes with HIF-1β to promote the transcription of a number of genes involved in angiogenesis, glycolysis, growth factor signaling, tumor invasion, and metastasis. CAY10585 is a novel small molecule inhibitor of HIF-1α accumulation and gene transcriptional activity. In a gene reporter assay using human Hep3B and AGS cell lines, CAY10585 prevented HIF-1 transcriptional activity with IC50 values of 2.6 and 0.7 μM, respectively. It blocks HIF-1α accumulation in Hep3B cells in a concentration and time-dependent manner, with complete inhibition at a concentration of 30 μM within 12 hours. CAY10585 also significantly suppresses transcription of the HIF-1 target genes VEGF and erythropoietin at 10 μM.

Uses

CAY10585 is a class of hypoxia-inducible factor (HIF-1) responsible for radiation resistance and poor prognosis in cancer therapy.

storage

Store at -20°C

OTAVA-BB 7070707015Supplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
TOKYO CHEMICAL INDUSTRY CO., LTD.
Tel
03-36680489
Email
Sales-JP@TCIchemicals.com
TCI Europe
Tel
320-37350700
Email
sales@tcieurope.eu
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com